Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/2012
11/07/2012CN102764438A Novel application of beta3 adrenoceptor agonist
11/07/2012CN102764427A Application of GPR50 (G protein-coupled receptor 50) as BACE1 (Beta-secretase 1) inhibitor and in preparation of drug for treatment of Alzheimer's disease
11/07/2012CN102764426A Scorpion venom protein polypeptide colon-targeted preparation and preparation method thereof
11/07/2012CN102764425A Peptide selection method
11/07/2012CN102764418A Medicine for treating anaudia and aphasia caused by apoplexy
11/07/2012CN102764415A Oral liquid for preventing and treating various pains
11/07/2012CN102764410A Traditional Chinese medicine for treating migraine headache
11/07/2012CN102764407A Traditional Chinese medicinal decoction for treating depression
11/07/2012CN102764401A Traditional Chinese medicine prescription for treating craniocerebral injury
11/07/2012CN102764385A Medicine for treating venereophobia and application of medicine
11/07/2012CN102764381A Traditional Chinese medicine composite for curing cerebral infarction sequelae
11/07/2012CN102764380A Traditional Chinese medicine composite for curing cerebrovascular disease sequelae
11/07/2012CN102764377A Chinese herba preparation used for treating epilepsy
11/07/2012CN102764376A Centipede scorpion pill
11/07/2012CN102764350A Chinese medicinal composition for treating rheumatoid bone diseases and arthralgia
11/07/2012CN102764347A Medicament for treating cold and complications thereof
11/07/2012CN102764340A Traditional Chinese medicine composite capable of improving sleep and preparation method and application thereof
11/07/2012CN102764305A Spleen-invigorating combined drug, preparation method and application thereof
11/07/2012CN102764287A Three-high prevention and treatment particulate agent
11/07/2012CN102764279A Use of selenium yeasts in the treatment of alzheimers disease
11/07/2012CN102764277A Suction therapy for repairing brain cells, containing cerebral hemorrhage and enhancing immune system
11/07/2012CN102764265A Application of rheum emodin-8-beta-D-glucoside in preparation of medicines and health-care products for treating synaptic dysfunctional diseases
11/07/2012CN102764257A Flupirtine maleate sustained release tablet
11/07/2012CN102764254A Levetiracetam drug composition and preparation method thereof
11/07/2012CN102764229A Compound haloperidol subcutaneously-implanted sustained-release agent and preparation and use methods thereof
11/07/2012CN102302521B Catharsius molossus extract, anti-anxiety medicament which takes catharsius molossus extract as active ingredient and preparation method and application thereof
11/07/2012CN102274276B Traditional Chinese medicinal composition for treating wind-cold type common cold
11/07/2012CN102218091B Application of cinnamon oil, cinnamyl aldehyde and derivatives of cinnamyl aldehyde in preparation of histamine H3 acceptor antagonist or inverse agonist medicaments
11/07/2012CN102198199B Plaster for treating facial nerve paralysis
11/07/2012CN102188661B Traditional Chinese medicine for removing arthralgia and preparation method thereof
11/07/2012CN102188566B Medicinal liquor for treating ischialgia
11/07/2012CN102180826B Histone deacetylase inhibitor containing alpha amino acid structure and application thereof
11/07/2012CN102114245B Special solvent for daidzein pre-emulsified injection and preparation method and purpose thereof
11/07/2012CN102106891B Cardio-cerebral refreshing sustained-release soft capsules and preparation method thereof
11/07/2012CN101928655B Schisandra chinensis health protection wine and preparation method thereof
11/07/2012CN101928230B Improved synthesis scheme for lacosamide
11/07/2012CN101904894B Application of lamiophlomis rotate total glycosides in preparing medicines
11/07/2012CN101897746B Composite used for relieving alcoholic intoxication and protecting liver and preparation method and application thereof
11/07/2012CN101874020B Piperidine derivatives as agonists of muscarinic receptors
11/07/2012CN101810683B Chinese medicinal compound preparation for curing migraine and preparation process thereof
11/07/2012CN101780224B New application of composition containing inula flower
11/07/2012CN101732695B Compound of brain protein hydrolyzate and maleic acid and method for preparing same
11/07/2012CN101601859B Application of nattokinase in preparing cerebral protective agent type drugs
11/07/2012CN101563350B Amorphous form of n-{2-fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo [1,5-a]pyrimidin-7-yl]-phenyl-N-methyl-acetamide
11/07/2012CN101541796B Novel substituted diaza spiro pyridinone derivatives for use in MCH-1 mediated diseases
11/07/2012CN101528710B Aminomethyl-4-imidazoles
11/07/2012CN101503365B Preparation of venlafaxine intermediate 1-[2-amino-1-(4-methoxy phenyl)ethyl] cyclohexanol
11/07/2012CN101353664B siRNA molecule expression vector for specific inhibition of IL-6 receptor protein expression, and construction method and use thereof
11/07/2012CN101247736B Compositions and methods for improving integrity of functional blood vessel, cellular survival and decreasing Programmed cell death in ischemia or after ischemia in the brain
11/07/2012CN101171009B Use of non-imidazole alkylamines histamine h3- receptor ligands in treatment of parkinson's disease obstructive sleep apnea, dementia with lewy bodies, vascular dementia
11/07/2012CN101167901B Chinese angelica and peony formula extraction, preparation and medical use thereof
11/07/2012CN101155781B Pyridine-3-carboxamide derivatives as cb1 inverse agonists
11/07/2012CN101001846B Novel alkynyl derivatives as modulators of metabotropic glutamate receptors
11/06/2012US8304414 Pyrazole compounds useful as protein kinase inhibitors
11/06/2012US8304409 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
11/06/2012US8303986 Hydrophilic/lipophilic polymeric matrix dosage formulation
11/06/2012US8303949 Prevention and treatment of oxidative stress disorders by glutathione and phase II detoxification enzymes
11/06/2012CA2495685C Aza-bicycloalkyl ethers and their use as alpha7-nachr agonists
11/06/2012CA2365532C Arpe-19 as a platform cell line for encapsulated cell-based delivery
11/02/2012CA2775624A1 New association between 4-{ 3-(cis-hexahydrocyclopenta (c) pyrrol -2 (1h)-yl ) propoxy } benzamide and an acetylcholinesterase inhibitor and the pharmacological composition withinthis association
11/01/2012WO2012149535A1 The use of angiotensin ii (at ii) type 1 receptor antagonist in the therapeutic treatment of autism
11/01/2012WO2012149478A2 Agents useful for treating friedreich's ataxia and other neurodegenerative diseases
11/01/2012WO2012149472A2 Methods, compositions, and kits for treating and preventing neurological conditions
11/01/2012WO2012149406A2 Assessing and treating humans with long qt syndrome
11/01/2012WO2012149365A2 Antibodies selective for pathological tau dimers and prefibrillar pathological tau oligomers and their uses in treatment, diagnosis and monitoring of tauopathies
11/01/2012WO2012149335A2 Small molecule inhibitors of rgs proteins
11/01/2012WO2012149295A2 Methods of administering anatabine to treat autism spectrum disorders and seizure disorders
11/01/2012WO2012149111A1 Methods of promoting cns neuronal repair by inhibiting lrp-1
11/01/2012WO2012149024A2 Dna aptamers for promoting remyelination
11/01/2012WO2012148926A2 Neurodegenerative disorders and muscle diseases implicating pufas
11/01/2012WO2012148887A2 Acute cognitive and mood effects of plant polysaccharides in adult human subjects
11/01/2012WO2012148308A1 Pharmacologically active alicyclic ν,ν'-substituted 3,7-diazabicyclo[3.3.1]nonane derivatives and drugs based thereon
11/01/2012WO2012148225A2 Sustained-release pharmaceutical composition comprising donepezil or pharmaceutically acceptable salt thereof having improved dissolution stability and method for manufacturing the same
11/01/2012WO2012147986A1 Stable pharmaceutical composition
11/01/2012WO2012147933A1 Pharmaceutical composition for treating lysosomal storage disease
11/01/2012WO2012147916A1 Amide compound and pharmaceutical application therefor
11/01/2012WO2012147890A1 Novel azole derivative
11/01/2012WO2012147805A1 Brain-targeting functional nucleic acid and use thereof
11/01/2012WO2012147765A1 Benzimidazole derivative having npy y5 receptor antagonist action
11/01/2012WO2012147764A1 5-membered ring aromatic heterocyclic derivative having npy y5 receptor antagonistic activity
11/01/2012WO2012147763A1 Oxazine derivative and bace 1 inhibitor containing same
11/01/2012WO2012147762A1 Pyridine derivative and bace-1 inhibitor containing same
11/01/2012WO2012147597A1 Camptocormia therapeutic agent
11/01/2012WO2012147099A1 Pharmaceutical compositions of levodopa, carbidopa and entacapone
11/01/2012WO2012147051A2 Food, particularly a beverage for human consumption
11/01/2012WO2012146724A2 Novel rock inhibitors
11/01/2012WO2012146651A1 Protein hydrolysates as agents for overcoming addiction
11/01/2012WO2012146644A1 Salt of an inhibitor of phosphodiesterase 10 enzyme
11/01/2012WO2012146552A1 Pyrazolidin-3-one derivatives
11/01/2012WO2012146551A1 Ethynyl derivatives as positive allosteric modulators of the mglur5
11/01/2012WO2012146383A1 Tapentadol for preventing and treating depression and anxiety
11/01/2012WO2012146371A1 Pharmaceutically acceptable cocrystals of n-[2-(7-methoxy-1-naphtyl)ethyl]acetamide and methods of their preparation
11/01/2012WO2012146052A1 Risperidone sustained release microsphere composition
11/01/2012WO2012145981A1 Adamantane or adamantane-like compounds as antitumor agents
11/01/2012WO2012145893A1 A composition of entacopone
11/01/2012WO2012115446A3 Compound based on 5-(substituted alkyl-aminomethyl) isoxazole acting as a t-type calcium channel antagonist
11/01/2012WO2012107890A3 Crystal forms of lurasidone chlorhydrate
11/01/2012WO2012106404A3 Diagnosis and treatment of neurological disorders through vipr2 and vpac2r
11/01/2012WO2012103282A3 Methods and compositions for treating alzheimer's disease
11/01/2012WO2012088100A3 Triclabendazole and fenbendazole for cell protection
1 ... 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 ... 1833